Biocomp - In Vitro Irritation Test (Medical device 10993-23)
Animal testing faces increasing ethical scrutiny and regulatory restrictions - validated alternative methods reducing animal use while maintaining predictive accuracy represent the future of safety assessment. In vitro skin irritation testing per ISO 10993-23 using MatTek EpiDerm™ reconstructed human epidermis provides human-relevant safety assessment while eliminating animal use through validated tissue construct methodology. The validated protocol exposes tissue constructs to test materials with subsequent MTT viability assessment providing quantitative data that predicts human skin responses, correlating with in vivo Draize scores through established prediction models. The reconstructed human epidermis model incorporates normal human keratinocytes forming stratified epithelium with functional barrier properties including stratum corneum, providing physiologically relevant tissue responses. Regulatory acceptance continues expanding with EU authorities preferring in vitro methods when validated alternatives exist, while global harmonization efforts promote alternative method adoption reducing animal testing. For medical device manufacturers, in vitro irritation testing provides earlier safety assessment during development screening materials before expensive in vivo studies, enables efficient material comparison testing multiple candidates rapidly, and demonstrates corporate responsibility regarding animal welfare. The quantitative viability data enables dose-response assessment revealing concentration-dependent effects, supporting formulation optimization minimizing irritation while maintaining functionality. Manufacturing validation confirms processing doesn't increase skin irritation potential, sterilization doesn't generate irritating degradation products, and aging maintains acceptable irritation profiles throughout shelf life. The human-derived tissue provides more relevant prediction of human responses than animal models, potentially reducing clinical surprises from species differences in skin sensitivity or metabolism.